Page last updated: 2024-10-29

imipramine and Cerebral Infarction, Middle Cerebral Artery

imipramine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pang, C1
Cao, L1
Wu, F1
Wang, L1
Wang, G1
Yu, Y1
Zhang, M1
Chen, L3
Wang, W1
Lv, W1
Zhu, J1
Pan, J1
Zhang, H1
Xu, Y1
Ding, L1
Zhang, G1
Yang, L1
Hua, X1
Zhou, B1
Miao, Z1
Li, J1
Hu, H1
Namaka, M1
Kong, J1
Xu, X1

Other Studies

2 other studies available for imipramine and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
The effect of trans-resveratrol on post-stroke depression via regulation of hypothalamus-pituitary-adrenal axis.
    Neuropharmacology, 2015, Volume: 97

    Topics: Animals; Antidepressive Agents; Brain Ischemia; Depressive Disorder; Disease Models, Animal; Dose-Re

2015
Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice.
    Scientific reports, 2015, Nov-17, Volume: 5

    Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Brain; Brain-Derived Neuro

2015